T

Touchlight

144 employees

Touchlight Genetics develops a DNA production platform designed for the development of DNA vaccines for oncology and infectious diseases.

Basic info

Industry

biotechnology research

Sectors

Genome editing
Biotechnology
Biopharma
enzymatic DNA
CDMO
Health Care
Oncology
Enzymatic technology
Infectious diseases
AAV
DNA therapeutics
DNA amplification
Lentivirus
DNA
DNA vaccines
synthetic DNA
mRNA
Gene therapy
Genetic Medicine
Contract manufacturing
Medical
Innovation
DNA vectors

Date founded

2008

Funding rounds raised

Total raised

$2.4M

from 2 investors over 2 rounds

T

Touchlight raised $2.4M on November 28, 2022

Investors: Bill & Melinda Gates Foundation

T

Touchlight raised undisclosed on December 12, 2017

Investors: Innovate UK

FAQ